Pharmaceutical Industry Market Reports
In our analytical reports, we cover a wide range of industries and markets in pharma & healthcare. We show you future prospects across a wide range of commercial areas:
- Novel branded pharmaceuticals – therapeutic applications and drug classes
- Biopharmaceuticals (biologics) and healthcare biotechnology, including drug delivery and other technologies
- Generic drugs, the Pharma supply chain and over-the-counter (OTC) medicines
- Outsourced services – clinical trials, Pharma manufacturing and other roles
- Diagnostic tests and instruments
- Medical devices – implants and other products.
You will find revenue forecasts in a Visiongain report. Our reports analyse and explain commercial prospects at overall world, submarket, national and product level, suiting the topics. That way, you assess opportunities and commercial potentials for healthcare industries and markets.
- Access to present and predicted trends, harnessing years of analytical experience and knowledge
- Data and discussions – including our 10-year revenue forecasts – for your research, analyses and decision making
- Tables, charts and lists to benefit your reports, proposals and presentations.
Our studies give you analysis from primary and secondary research. You receive information found only in our work– quantitative and qualitative analyses with independent predictions. Many commercial opportunities exist; we show you where these are and explain their significance and potential from this decade onwards. You can rely on our reports to help you stay ahead.
If you are interested in receiving more information about our reports or have any query, please contact us through our online form.
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031
Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.
08 January 2021
Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030
The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.
07 January 2021
Visiongain Publishes Inactivated Vaccines Market Report 2020-2030
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.
07 January 2021
Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031
The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.
06 January 2021
